Ephraim Heiliczer is a Partner in the Intellectual Property and Regulatory Compliance Group at Pearl Cohen’s Tel Aviv office.
Ephraim has a strong background in medical science and has been involved in numerous life science and medical device oppositions and infringement actions as well as in patent prosecution and patent term extensions (PTE).
Ephraim’s scientific background also provides him with an advantage in regulatory matters involving the Israeli Ministry of Health and Israeli Standards Institute.
In addition to regulatory work, Ephraim has broad experience in compliance. Ephraim has authored book chapters on Pharmaceutical and Intellectual Property compliance. Ephraim is a thought leader and has spoken, among others at ACC and AIPPI conferences in Israel.
Ephraim has also been active in litigation, litigating cases involving drug release profiles and pharmacokinetics, drug metabolism, anti-HIV agents, CNS drugs and medical devices. Ephraim has also been involved in precedent setting PTE litigation.
During the course of his work, Ephraim has worked extensively with some of the world’s leading scientific experts and his scientific background was paramount in his collaborations with them.
Ephraim is presently a JSD candidate at Columbia Law School.